Why the study?
Are gadolinium-based contrast agents safe in children undergoing contrast-enhanced MRI?
Are gadolinium-based contrast agents safe in children undergoing contrast-enhanced MRI?
Gadolinium-based contrast agents appear safe for use in children undergoing MRI, with low rates of adverse reactions and no reported cases of nephrogenic systemic fibrosis.
Reassures on gadolinium safety in pediatric MRI; extends adult data but leaves open need for prospective validation.
Gadolinium-based contrast agent–associated adverse reaction rates in children undergoing contrast-enhanced MRI were low for acute physiologic reactions, acute allergic-like reactions, and delayed reactions, with no nephrogenic systemic fibrosis reported.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: